Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company's Chief Business Officer
1/7/2010 9:05:46 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Constellation Pharmaceuticals, Inc. today announced that it has appointed Kerry K. Reinertsen, Ph.D. as the company’s Chief Business Officer. Dr. Reinertsen will manage Constellation’s corporate and business development activities, including the formation, implementation and management of research and development alliances to maximize value creation from its significant set of R&D assets.
comments powered by